Pharmaceutical Excipients Market - Global Size, Share, Trends, Growth and Forecast Year ( 2022 – 2032 )
Pharmaceutical Excipients Market Dynamics
Pharmaceutical Excipients Market by Product Type (Organic Chemicals, Inorganic Chemicals, and Others), Functionality (Fillers and Diluents, Suspension, and Viscosity Agents, Coating Agents, Binders, Disintegrants, Colorants, Lubricants and Glidants, Preservatives, Emulsifying Agents, Flavoring Agents and Sweeteners, Other Functionalities), Formulations (Topical Formulations, Oral Formulations, Parenteral Formulations, Other Formulations), End-Users(Pharmaceuticals Companies, Research Organization, Academics, Others) and Geographic Regions (North America, Europe, Asia Pacific, Latin America, Middle East and Africa): Industry Trends and Global Forecasts, 2023-2032.
Market Size and Overview:
The pharmaceutical excipients market has witnessed substantial growth, with a projected market value of $16.4 billion by 2032, growing at a CAGR of 5.9% from 2023 to 2032. This growth can be attributed to various factors such as the expanding pharmaceuticals market, the increasing demand for functional excipients, the surge in the generics market, the rising uptake of biopharmaceuticals, and the adoption of orphan drugs. The market encompasses a wide range of excipients that play crucial roles in pharmaceutical formulations. The emergence of multifunctional excipients, the shift of pharmaceutical manufacturing to emerging countries, and the growth of the biosimilars market present significant growth opportunities. However, stringent regulatory requirements for drug and excipient approvals, as well as the time and cost-intensive drug development process, pose challenges to market growth during the forecast period.
Pharmaceutical Excipients Market: Report Scope
Base Year Market Size
Forecast Year Market Size
- Organic Chemicals
- Inorganic Chemicals
- Fillers and Diluents
- Suspending and Viscosity Agents
- Coating Agents
- Lubricants and Glidants
- Emulsifying Agents
- Flavoring Agents and Sweeteners
- Other Functionalities
- Topical Formulations
- Oral Formulations
- Parenteral Formulations
- Other Formulations
- Pharmaceuticals Companies
- Research Organization
- North America
- Asia Pacific
- Latin America
- Middle East and Africa
Organic Chemicals: The organic chemicals segment holds the dominant share in the pharmaceutical excipients market. This can be attributed to the non-toxic nature and efficacy of organic chemicals as excipients for oral drug formulations. Within the organic chemicals segment, oleochemicals, carbohydrates, petrochemicals, proteins, and other organic chemicals contribute to the overall market growth.
Oral Formulations: The oral formulations segment represents a substantial portion of the pharmaceutical excipients market. With the majority of pharmaceutical products being administered orally, excipients are crucial in enhancing drug stability, taste masking, and controlled release. The increasing prevalence of chronic diseases and the growing aging population drive the demand for oral drug formulations, thereby propelling the growth of this segment.
North America, region boasts one of the largest and most mature markets, primarily driven by the United States. The well-established pharmaceutical industry, extensive research and development activities, and the presence of major pharmaceutical companies contribute to the market's dominance. Europe, holds the largest market share, driven by the presence of major pharmaceutical players and the growing demand for high-quality pharmaceutical products. The emphasis on generics and biosimilars in Europe fuels the need for novel excipients, supporting market growth. The Asia Pacific region showcases substantial growth potential, attributed to the increasing population, rising healthcare expenditure, and the expansion of the pharmaceutical manufacturing sector in countries like China and India. Latin America demonstrates steady growth, driven by improving healthcare infrastructure, rising disposable incomes, and an increasing demand for quality pharmaceutical products. Brazil, Mexico, and Argentina are key markets within the region. Lastly, the Middle East and Africa exhibit emerging market opportunities, driven by an expanding pharmaceutical industry, rising healthcare investments, and the growing prevalence of chronic diseases. The United Arab Emirates, Saudi Arabia, and South Africa are notable contributors to the market's growth in this region.
Several factors drive the growth of the pharmaceutical excipients market. Firstly, the surge in the generics market plays a significant role. The rise in generic drug production and usage fuels the demand for pharmaceutical excipients. As more generic drugs enter the market, there is a need for excipients to formulate these medications effectively and ensure their quality and safety.
Furthermore, the increasing demand for functionality excipients drives market growth. Functionality excipients are specialized ingredients that enhance the performance and effectiveness of pharmaceutical formulations. They play a crucial role in drug stability, solubility, and bioavailability, contributing to improved patient outcomes.
rapid advancements in nanotechnology have a positive impact on the pharmaceutical excipients market. Nanotechnology enables the development of innovative drug delivery systems and formulations, which require specialized excipients. These excipients help enhance drug delivery, improve therapeutic efficacy, and enable targeted treatment approaches. Moreover, the recent expiration of patents for several drugs drives the demand for pharmaceutical excipients. With the expiration of patents, generic versions of these drugs enter the market, leading to increased production and the need for excipients in their formulations.
The pharmaceutical excipients market faces challenges related to the cost and time-intensive drug development process. Developing new drugs involves extensive research, clinical trials, and regulatory approvals, which can be time-consuming and costly. Additionally, safety and quality concerns are critical challenges.
The pharmaceutical excipients market is led by prominent players such as Ashland Global Holdings, BASF SE, DuPont, Roquette Frères, Evonik Industries AG, Associated British Foods, Archer Daniels Midland Company, Lubrizol Corporation, Croda International, and Kerry Group among other players. These companies have established a strong market presence and possess extensive expertise in the production and supply of pharmaceutical excipients. They have robust distribution networks and offer a wide range of excipient solutions to cater to the diverse needs of the pharmaceutical industry.
In February 2022, Kerry Group, a leading taste and nutrition company, made significant biotechnology acquisitions to expand its expertise and capabilities. The company acquired c-LEcta, a biotechnology innovation company specializing in precision fermentation and bio-transformation, as well as Enmex, a Mexican-based enzyme manufacturer.
In March 2022, CD Formulation launched tailored solutions for increased bioavailability excipients, addressing the long-standing challenge of poor bioavailability in drug development. Their specialized formulations aim to improve the absorption and effectiveness of pharmaceutical products, offering innovative solutions to enhance patient outcomes.